AMED logo

AMED

Asia, Tokyo, Japan, Tokyo

Description

Japan Agency for Medical Research and Development is an independent japanese medical research and development organization.

Investor Profile

AMED has made 3 investments, with 2 in the past 12 months and 67% as lead.

Stage Focus

  • Grant (67%)
  • Corporate Round (33%)

Country Focus

  • Japan (67%)
  • United States (33%)

Industry Focus

  • Business Information Systems
  • Document Management
  • Information Services
  • Manufacturing
  • Biotechnology
  • Health Care
  • Therapeutics
  • Alternative Medicine
  • Clinical Trials
  • Outpatient Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AMED frequently co-invest with?

Hamari Chemicals
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Chiyoda Corporation
Asia, Kanagawa, Japan, Yokohama
Co-Investments: 1
Kishida Japan
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Co-Investments: 1
Nagase & Co
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Nakamura Choukou
Asia, Osaka, Japan, Osaka
Co-Investments: 1
Microwave Chemical
Asia, Osaka, Japan, Suita
Co-Investments: 1
Mitsubishi Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by AMED?

RegCell

Osaka, Osaka, Japan

RegCell is a novel therapeutics company.

Alternative MedicineClinical TrialsOutpatient Care
GrantMar 18, 2025
Amount Raised: $37,300,000
Shinobi Therapeutics

South San Francisco, California, United States

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

BiotechnologyHealth CareTherapeutics
GrantAug 6, 2024
Amount Raised: $59,000,000
PeptiStar

Settsu, Osaka, Japan

PeptiStar continually strives to develop novel manufacturing technologies to address needs in every stage of the peptide value chain.

Business Information SystemsDocument ManagementInformation ServicesManufacturing
Corporate RoundApr 18, 2018
Amount Raised: $186,286,291